title: A Drug Interaction Between Cabozantinib and Warfarin in a Patient With Renal Cell Carcinoma.
authors.affiliation: Department of Pharmacy, University of Washington Medical Center, Seattle, WA. Electronic address: foxxlupo@seattlecca.org.
authors.forename: William Travis
authors.initials: WT
authors.lastname: Foxx-Lupo
authors.affiliation: Department of Pharmacy, University of Washington Medical Center, Seattle, WA.
authors.forename: Sarah
authors.initials: S
authors.lastname: Sing
authors.affiliation: Department of Pharmacy, University of Washington Medical Center, Seattle, WA.
authors.forename: Laura
authors.initials: L
authors.lastname: Alwan
authors.affiliation: Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
authors.forename: Scott S
authors.initials: SS
authors.lastname: Tykodi
mesh_terms: D000813:Anilides / Q000494:pharmacology* / Q000627:therapeutic use; D000925:Anticoagulants / Q000494:pharmacology* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000556:secondary; D003131:Combined Modality Therapy; D004344:Drug Incompatibility; D006801:Humans; D019934:International Normalized Ratio; D007680:Kidney Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000188:drug therapy; D011725:Pyridines / Q000494:pharmacology* / Q000627:therapeutic use; D016896:Treatment Outcome; D014859:Warfarin / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000813:Anilides; D000925:Anticoagulants; D000970:Antineoplastic Agents; D011725:Pyridines; C558660:cabozantinib; D014859:Warfarin
keywords: Cabozantinib; Drug interaction; Renal cell carcinoma; Tyrosine kinase inhibitor; Warfarin